Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C†Calogero Cammà, Antonio Craxfì, Savino Bruno et al.|Hepatology|2005Cited by 166
Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trialSavino Bruno, G. Pinzello, Chiara Rebucci et al.|Journal of Hepatology|2004Cited by 95
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infectionBarbara Oliviero, Mario U. Mondelli, Dalila Mele et al.|Journal of Hepatology|2013Cited by 55
<i><scp>HCV E1E</scp>2‐<scp>MF</scp>59</i> vaccine in chronic hepatitis <scp>C</scp> patients treated with <scp>PEG</scp>‐<scp>IFN</scp>α2a and <scp>R</scp>ibavirin: a randomized controlled trialP. Colombatto, Ferruccio Bonino, Maurizia Rossana Brunetto et al.|Journal of Viral Hepatitis|2013Cited by 22
HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort StudyLoreta A. Kondili, Salvatore Petta, Weimer LE et al.|Journal of Hepatology|2016Cited by 5